Patent details

Basic Information

Publication number:

EP2740487

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131953010

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ALPHA-I ANTITRYPSIN FOR TREATING EXACERBATION EPISODES OF PULMONARY DISEASES

French Title of Invention:

Alpha-1-Antitrypsine pour le traitement des épisodes d'exacerbation des maladies pulmonaires

German Title of Invention:

Alpha-I-Antitrypsin zur Behandlung von Verschlimmerungsepisoden bei Lungenerkrankungen

SPC Number:

Dates

Filing date:

08/02/2007

Grant date:

28/02/2018

EP Publication Date:

11/06/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

28/02/2018

EP B1 Publication Date:

28/02/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

08/02/2019

Expiration date:

08/02/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/02/2018

 

 

Name:

Kamada Ltd.

Address:

7 Sapir Street, Kiryat Weizmann Science Park, 74140 Ness-Ziona, Israel (IL)

Inventor

Name:

Bauer, Shabtai

Address:

Israel (IL)

Priority

1

Priority Number:

771465 P

Priority Date:

09/02/2006

Priority Country:

United States (US)

2

Priority Number:

773654 P

Priority Date:

16/02/2006

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 38/57; A61P 11/00;

Publication

European Patent Bulletin

Issue number:

201809

Publication date:

28/02/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages